The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Am J Psychiatry 114:751-752, February 1958
doi: 10.1176/appi.ajp.114.8.751
© 1958 American Psychiatric Association
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via Google Scholar
Google Scholar
* Articles by TURNER, WM. J.
* Articles by MERLIS, S.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by TURNER, WM. J.
* Articles by MERLIS, S.

CHEMOTHERAPEUTIC TRIALS IN PSYCHOSIS: III

2-Brom-d-Lysergic Acid Diethylamide (BOL 148)

WM. J. TURNER M. D., and SIDNEY MERLIS M. D.1

1 Research Division, Central Islip State Hospital, Central Islip, N. Y.

BOL 148 administered to chronic schizophrenics, 1 mg. t.i.d. to 6 subjects for 2 weeks, or 5 mg. q.i.d. for 3 days to 3 subjects, had no evident effect on their psychoses.







Get information about faster international access.

Privacy Policy

Copyright © 1958 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org